Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease

The present disclosure relates to processes for the preparation of the phosphorylated L-Dopa prodrug L-Dopa 3',4'-Diphosphate from its protected precursor.

Saved in:

Bibliographic Details
Main Authors	Henry, Rodger F, Ho, Raimundo, Huang, Ye, Dempah, Kassibla E, Chan, Vincent S, Cardinal-David, Benoit, Wang, Zhi, Zhang, Geoff G, Stella, Valentino J, Huters, Alexander D, Krabbe, Scott W, Lao, Yanbin, Mayer, Peter T, Enright, Brian P, Lou, Xiaochun, Mackey, Sean E, Matulenko, Mark A, Stambuli, James, Miller, Christopher P, Voight, Eric A, Klix, Russell C, Kym, Philip R
Format	Patent
Language	English
Published	26.04.2024
Subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online Access	Get full text

Cover

Loading…

More Information
Summary:	The present disclosure relates to processes for the preparation of the phosphorylated L-Dopa prodrug L-Dopa 3',4'-Diphosphate from its protected precursor.
Bibliography:	Application Number: NZ20150769153